Form 4: Medpace Director Robert Kraft Converts Restricted Stock Units to Common Shares

Medpace Holdings, Inc. Director Robert O. Kraft converted 57 restricted stock units into common shares on June 30, 2025, as part of a pre-scheduled vesting.

Summary

• Robert O. Kraft, a Director of Medpace Holdings, Inc. (MEDP), acquired 57 shares of common stock.
• This acquisition resulted from the conversion of 57 restricted stock units (RSUs).
• The transaction occurred on June 30, 2025.
• Following this transaction, Robert O. Kraft directly beneficially owns 776 shares of common stock.
• He also directly beneficially owns 113 restricted stock units.
• The 57 RSUs were part of a larger grant of 227 RSUs awarded on November 29, 2024, which vest in four approximately equal installments.
• The vesting dates for the 227 RSUs are March 31, 2025, June 30, 2025, September 30, 2025, and December 31, 2025.

Sentiment

Score: 7

Explanation: The transaction is a routine, pre-scheduled vesting of restricted stock units, indicating standard compensation practices and continued equity alignment of a director. It is a neutral to slightly positive event as it increases the director's direct share ownership.

Positives

• The conversion of restricted stock units into common shares indicates a pre-scheduled compensation event, aligning director incentives with shareholder interests.
• The director continues to hold a significant number of common shares (776) and additional restricted stock units (113), demonstrating continued equity alignment.

Future Outlook

NA

Industry Context

This filing is a routine insider transaction report and does not provide broader industry context or trends. It reflects standard equity compensation practices for corporate directors.

Comparison to Industry Standards

• This is a standard RSU vesting event, common across industries for executive and director compensation. The specific number of shares or RSUs granted would need context of the director's overall compensation package and company size to compare to industry benchmarks, which is not provided in this document.

Stakeholder Impact

• Shareholders: The conversion of RSUs into common stock slightly increases the number of outstanding shares, but this is a pre-planned compensation event and generally not dilutive in a significant way. It aligns the director's interests with shareholders.
• Employees: No direct impact on employees mentioned.
• Customers/Suppliers/Creditors: No direct impact on these stakeholders mentioned.

Next Steps

• Future vesting of remaining restricted stock units on September 30, 2025, and December 31, 2025.

Key Dates

Recommendation

Keywords

Medpace Holdings, MEDP, Robert O. Kraft, Form 4, Insider Transaction, Restricted Stock Units, RSU Conversion, Director Compensation, Equity Ownership